Oral fluid testing for drugs of abuse

Clinical Chemistry

Volumn 55, Issue 11, 2009, Pages 1910-1931

  Bosker, Wendy M ^a,b   Huestis, Marilyn A ^b  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHETAMINE DERIVATIVE; BENZODIAZEPINE DERIVATIVE; CANNABINOID DERIVATIVE; COCAINE DERIVATIVE; OPIATE DERIVATIVE; CANNABINOID; COCAINE; NARCOTIC ANALGESIC AGENT;

CRIMINAL JUSTICE; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; IMMUNOASSAY; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; MENTAL HEALTH SERVICE; REVIEW; SCREENING TEST; SENSITIVITY AND SPECIFICITY; SUBSTANCE ABUSE; URINALYSIS; VISCOSITY; CHEMISTRY; INSTRUMENTATION; METHODOLOGY; SALIVA; STANDARD;

AMPHETAMINES; ANALGESICS, OPIOID; BENZODIAZEPINES; CANNABINOIDS; COCAINE; HUMANS; SALIVA; SUBSTANCE ABUSE DETECTION;

EID: 70449701839     PISSN: 00099147     EISSN: 15308561     Source Type: Journal    
DOI: 10.1373/clinchem.2008.108670     Document Type: Review

References (130)

1. Choo RE, Huestis MA. Oral fluid as a diagnostic tool. Clin Chem Lab Med 2004;42:1273-1287
2. Gallardo E, Queiroz JA. The role of alternative specimens in toxicological analysis. Biomed Chromatogr 2008;22:795-821.
3. Langel K, Engblom C, Pehrsson A, Gunnar T, Ariniemi K, Lillsunde P. Drug testing in oral fluid-evaluation of sample collection devices. J Anal Toxicol 2008;32:393-401.
4. Verstraete AG. Oral fluid testing for driving under the influence of drugs: history, recent progress and remaining challenges. Forensic Sci Int 2005;150:143-150
5. Department of Health and Human Services, SAMHSA. Proposed revisions to mandatory guidelines for federal workplace drug testing programs. Federal Register 2004;69:19673-19732
6. Bush DM. The US mandatory guidelines for federal workplace drug testing programs: current status and future considerations. Forensic Sci Int 2008;174:111-119
7. National Institute on Drug Abuse. Drugged driving info facts. www.nida.nih.gov (Accessed October 2008).
8. Verstraete A, Puddu M. Evaluation of different roadside drug tests. www.rosita.org (Accessed February 2009).
9. Verstraete A, Raes E. Rosita-2 project: final report. www.rosita.org (Accessed February 2009).
10. Drummer OH, Gerostamoulos D, Chu M, Swann P, Boorman M, Cairns I. Drugs in oral fluid in randomly selected drivers. Forensic Sci Int 2007; 170:105-110 (Pubitemid 47096771)
11. Walsh JM, Verstraete AG, Huestis MA, Morland J. Guidelines for research on drugged driving. Addiction 2008;103:1258-1268
12. Crouch DJ. Oral fluid collection: the neglected variable in oral fluid testing. Forensic Sci Int 2005;150:165-173 (Pubitemid 41583219)
13. Huestis MA, Cone EJ. Relationship of Delta 9-tetrahydrocannabinol concentrations in oral fluid and plasma after controlled administration of smoked cannabis. J Anal Toxicol 2004;28: 394-399
14. Kintz P, Brunet B, Muller JF, Serra W, Villain M, Cirimele V, Mura P. Evaluation of the Cozart DDSV test for cannabis in oral fluid. Ther Drug Monit 2009;31:131-134
15. Dickson S, Park A, Nolan S, Kenworthy S, Nicholson C, Midgley J, et al. The recovery of illicit drugs from oral fluid sampling devices. Forensic Sci Int 2007;165:78-84. (Pubitemid 44854347)
16. Kauert GF, Iwersen-Bergmann S, Toennes SW. Assay of Delta9- tetrahydrocannabinol (THC) in oral fluid-evaluation of the OraSure oral specimen collection device. J Anal Toxicol 2006;30: 274-277 (Pubitemid 44285269)
17. Concheiro M, de Castro A, Quintela O, Cruz A, Lopez-Rivadulla M. Confirmation by LC-MS of drugs in oral fluid obtained from roadside testing. Forensic Sci Int 2007;170:156-162 (Pubitemid 47088884)
18. Crouch DJ, Walsh JM, Cangianelli L, Quintela O. Laboratory evaluation and field application of roadside oral fluid collectors and drug testing devices. Ther Drug Monit 2008;30:188-195
19. Biermann T, Schwarze B, Zedler B, Betz P. Onsite testing of illicit drugs: the use of the drug-testing device "Toxiquick." Forensic Sci Int 2004;143:21-25
20. Walsh JM, Crouch DJ, Danaceau JP, Cangianelli L, Liddicoat L, Adkins R. Evaluation of ten oral fluid point-of-collection drug-testing devices. J Anal Toxicol 2007;31:44-54. (Pubitemid 46376973)
21. Cooper G, Wilson L, Reid C, Main L, Hand C. Evaluation of the Cozart RapiScan drug test system for opiates and cocaine in oral fluid. Forensic Sci Int 2005;150:239-243 (Pubitemid 41583228)
22. Cooper G, Wilson L, Reid C, Baldwin D, Hand C, Spiehler V. Validation of the Cozart® microplate EIA for analysis of opiates in oral fluid. Forensic Sci Int 2005;154:240-246 (Pubitemid 41354979)
23. Cooper G, Wilson L, Reid C, Baldwin D, Hand C, Spiehler V. Validation of the Cozart microplate EIA for cocaine and metabolites in oral fluid. J Anal Toxicol 2004;28:498-503. (Pubitemid 39150373)
24. Cooper G, Wilson L, Reid C, Hand C, Spiehler V. Validation of the Cozart® Amphetamine Microplate EIA for the analysis of amphetamines in oral fluid. Forensic Sci Int 2006;159:104-112
25. Wong RC, Tran M, Tung JK. Oral fluid drug tests: effects of adulterants and foodstuffs. Forensic Sci Int 2005;150:175-180 (Pubitemid 41583220)
26. Dams R, Murphy CM, Choo RE, Lambert WE, De Leenheer AP, Huestis MA. LC-atmospheric pressure chemical ionization-MS/MS analysis of multiple illicit drugs, methadone, and their metabolites in oral fluid following protein precipitation. Anal Chem 2003;75:798-804. (Pubitemid 36232432)
27. Maurer HH. Advances in analytical toxicology: the current role of liquid chromatography-mass spectrometry in drug quantification in blood and oral fluid. Anal Bioanal Chem 2005;381:110-118
28. Samyn N, Laloup M, De Boeck G. Bioanalytical procedures for determination of drugs of abuse in oral fluid. Anal Bioanal Chem 2007;388: 1437-1453 (Pubitemid 47150871)
29. Wood M, Laloup M, Samyn N, Fernandez MDR, de Bruijn EA, Maes RAA, De Boeck G. Recent applications of liquid chromatography-mass spectrometry in forensic science. J Chromatogr 2006;1130:3-15. (Pubitemid 44425267)
30. Dams R, Huestis MA, Lambert WE, Murphy CM. Matrix effect in bio-analysis of illicit drugs with LC-MS/MS: influence of ionization type, sample preparation, and biofluid. J Am Soc Mass Spectrom 2003;14:1290-1294 (Pubitemid 37330133)
31. Cone EJ, Huestis MA. Interpretation of oral fluid tests for drugs of abuse. Ann NY Acad Sci 2007;1098:51-103. (Pubitemid 47092558)
32. Speedy T, Baldwin D, Jowett G, Gallina M, Jehanli A. Development and validation of the Cozart® DDS oral fluid collection device. Forensic Sci Int 2007;170:117-120
33. Quintela O, Crouch DJ, Andrenyak DM. Recovery of drugs of abuse from the Immunalysis Quantisal oral fluid collection device. J Anal Toxicol 2006;30:614-616 (Pubitemid 44600855)
34. Hawks RL, Chiang NC. Urine testing for drugs of abuse. National Institute on Drug Abuse 1986. http://www.drugabuse.gov/pdf/monographs/73. pdf (Accessed November 2008).
35. Huestis MA, Dickerson S, Cone EJ. Can saliva THC levels be correlated to behavior? From: American Academy of Forensic Sciences annual meeting; 1992. p 190.
36. Ramaekers JG, Moeller MR, van Ruitenbeek P, Theunissen EL, Schneider E, Kauert G. Cognition and motor control as a function of Delta9-THC concentration in serum and oral fluid: limits of impairment. Drug Alcohol Depend 2006;85: 114-122 (Pubitemid 44468137)
37. Kauert GF, Ramaekers JG, Schneider E, Moeller MR, Toennes SW. Pharmacokinetic properties of Delta9-tetrahydrocannabinol in serum and oral fluid. J Anal Toxicol 2007;31:288-293 (Pubitemid 46911627)
38. Niedbala S, Kardos K, Salamone S, Fritch D, Bronsgeest M, Cone EJ. Passive cannabis smoke exposure and oral fluid testing. J Anal Toxicol 2004;28:546-552 (Pubitemid 39314852)
39. Niedbala RS, Kardos KW, Fritch DF, Kunsman KP, Blum KA, Newland GA, et al. Passive cannabis smoke exposure and oral fluid testing, II: two studies of extreme cannabis smoke exposure in a motor vehicle. J Anal Toxicol 2005;29: 607-615
40. Moore C, Coulter C, Rana S, Vincent M, Soares J. Analytical procedure for the determination of the marijuana metabolite 11-nor-Delta9- tetrahydrocannabinol-9-carboxylic acid in oral fluid specimens. J Anal Toxicol 2006;30:409-412 (Pubitemid 44371480)
41. Moore C, Ross W, Coulter C, Adams L, Rana S, Vincent M, Soares J. Detection of the marijuana metabolite 11-nor-Delta9-tetrahydrocannabinol-9- carboxylic acid in oral fluid specimens and its contribution to positive results in screening assays. J Anal Toxicol 2006;30:413-418 (Pubitemid 44371481)
42. Moore C, Rana S, Coulter C, Day D, Vincent M, Soares J. Detection of conjugated 11-nor- Delta9-tetrahydrocannabinol-9-carboxylic acid in oral fluid. J Anal Toxicol 2007;31:187-194 (Pubitemid 46708658)
43. Milman G, Lowe RH, Huestis MA. Simultaneous identification and quantification of Cannabis sativa cannabinoids and metabolites in oral fluid. From: Society of Forensic Toxicologists annual meeting; 2008 Oct 27-31; Phoenix, AZ.
44. Niedbala RS, Kardos KW, Fritch DF, Kardos S, Fries T, Waga J, et al. Detection of marijuana use by oral fluid and urine analysis following single-dose administration of smoked and oral marijuana. J Anal Toxicol 2001;25:289-303. (Pubitemid 32656280)
45. Walsh JM. New technology and new initiatives in US workplace testing. Forensic Sci Int 2008; 174:120-124
46. Moore C, Rana S, Coulter C. Determination of meperidine, tramadol and oxycodone in human oral fluid using solid phase extraction and gas chromatography-mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci 2007; 850:370-375 (Pubitemid 46618183)
47. De Giovanni N, Fucci N, Scarlata S, Donzelli G. Buprenorphine detection in biological samples. Clin Chem Lab Med 2005;43:1377-1379
48. Kim I, Barnes AJ, Oyler JM, Schepers R, Joseph RE Jr, Cone EJ, et al. Plasma and oral fluid pharmacokinetics and pharmacodynamics after oral codeine administration. Clin Chem 2002;48: 1486-1496 (Pubitemid 34925783)
49. Kacinko SL, Barnes AJ, Kim I, Moolchan ET, Wilson L, Cooper GA, et al. Performance characteristics of the Cozart® RapiScan Oral Fluid Drug Testing System for opiates in comparison to ELISA and GC/MS following controlled codeine administration. Forensic Sci Int 2004;141: 41-48
50. Rohrig TP, Moore C. The determination of morphine in urine and oral fluid following ingestion of poppy seeds. J Anal Toxicol 2003;27:449-452 (Pubitemid 37185854)
51. Schepers RJF, Oyler JM, Joseph RE Jr, Cone EJ, Moolchan ET, Huestis MA. Methamphetamine and amphetamine pharmacokinetics in oral fluid and plasma after controlled oral methamphetamine administration to human volunteers. Clin Chem 2003;49:121-132
52. Huestis MA, Cone EJ. Methamphetamine disposition in oral fluid, plasma, and urine. Ann NY Acad Sci 2007;1098:104-121
53. Laloup M, Tilman G, Maes V, De Boeck G, Wallemacq P, Ramaekers J, Samyn N. Validation of an ELISA-based screening assay for the detection of amphetamine, MDMA and MDA in blood and oral fluid. Forensic Sci Int 2005;153: 29-37.
54. Wood M, Laloup M, Ramirez Fernandez Mdel M, Jenkins KM, Young MS, Ramaekers JG, et al. Quantitative analysis of multiple illicit drugs in preserved oral fluid by solid-phase extraction and liquid chromatography-tandem mass spectrometry. Forensic Sci Int 2005;150:227-238 (Pubitemid 41583227)
55. Peters FT, Samyn N, Kraemer T, Riedel WJ, Maurer HH. Negative-ion chemical ionization gas chromatography-mass spectrometry assay for enantioselective measurement of amphetamines in oral fluid: application to a controlled study with MDMA and driving under the influence cases. Clin Chem 2007;53:702-710 (Pubitemid 46580241)
56. European Monitoring Centre for Drugs and Drug Addiction. Annual report: the state of the drugs problem in Europe. www.emcdda.europa.eu (Accessed December 2008).
57. Kolbrich E, Barnes A, Gorelick DA, Boyd SJ, Cone EJ, Huestis MA. Major and minor metabolites of cocaine in human plasma following controlled subcutaneous cocaine administration. J Anal Toxicol 2006;30:501-510 (Pubitemid 44600839)
58. Kolbrich EA, Kelly TL, Barnes AJ, Kim I, Moolchan ET, Cone EJ, Huestis MA. Saliva/plasma ratios of cocaine, ecgonine methyl ester and benzoylecgonine following controlled cocaine administration. From: Society of Forensic Toxicologists annual meeting; 2005 Oct 17-21; Nashville, TN.
59. Jufer R, Walsh SL, Cone EJ, Sampson-Cone A. Effect of repeated cocaine administration on detection times in oral fluid and urine. J Anal Toxicol 2006;30:458-462 (Pubitemid 44371488)
60. Busto UE, Kaplan HL, Wright CE, Gomez-Mancilla B, Zawertailo L, Greenblatt DJ, Sellers EM. A comparative pharmacokinetic and dynamic evaluation of alprazolam sustainedrelease, bromazepam, and lorazepam. J Clin Psychopharmacol 2000;20:628-635 (Pubitemid 30953802)
61. Samyn N, DeBoeck G, Cirimele V, Verstraete A, Kintz P. Detection of flunitrazepam and 7-aminoflunitrazepam in oral fluid after controlled administration of Rohypnol. J Anal Toxicol 2002;26:211-215 (Pubitemid 34563955)
62. Laloup M, Fernandez MDR, Wood M, Maes V, De Boeck G, Vanbeckevoort Y, Samyn N. Detection of diazepam in urine, hair and preserved oral fluid samples with LC-MS-MS after single and repeated administration of Myolastan (R) and Valium (R). Anal Bioanal Chem 2007;388: 1545-1556 (Pubitemid 47150880)
63. Smink BE, Hofman BJ, Dijkhuizen A, Lusthof KJ, de Gier JJ, Egberts AC, Uges DR. The concentration of oxazepam and oxazepam glucuronide in oral fluid, blood and serum after controlled administration of 15 and 30 mg oxazepam. Br J Clin Pharmacol 2008;66:556-560
64. Toennes SW, Kauert GF, Steinmeyer S, Moeller MR. Driving under the influence of drugs - evaluation of analytical data of drugs in oral fluid, serum and urine, and correlation with impairment symptoms. Forensic Sci Int 2005; 152:149-155 (Pubitemid 40839281)
65. Toennes SW, Steinmeyer S, Maurer HJ, Moeller MR, Kauert GF. Screening for drugs of abuse in oral fluid - correlation of analysis results with serum in forensic cases. J Anal Toxicol 2005;29: 22-27 (Pubitemid 40128941)
66. Engblom C, Gunnar T, Rantanen A, Lillsunde P. Driving under the influence of drugs - amphetamine concentrations in oral fluid and whole blood samples. J Anal Toxicol 2007;31: 276-280 (Pubitemid 46911625)
67. Pehrsson A, Gunnar T, Engblom C, Seppä H, Jama A, Lillsunde P. Roadside oral fluid testing: comparison of the results of Drugwipe 5 and Drugwipe Benzodiazepines on-site tests with laboratory confirmation results of oral fluid and whole blood. Forensic Sci Int 2008;175:140-148 (Pubitemid 351199963)
68. Gjerde H, Normann PT, Pettersen BS, Assum T, Aldrin M, Johansen U, et al. Prevalence of alcohol and drugs among Norwegian motor vehicle drivers: a roadside survey. Accid Anal Prev 2008;40:1765-1772
69. Wylie FM, Torrance H, Seymour A, Buttress S, Oliver JS. Drugs in oral fluid - part II: investigation of drugs in drivers. Forensic Sci Int 2005; 150:199-204. (Pubitemid 41583223)
70. Bernhoft IM, Steentoft A, Johansen SS, Klitgaard NA, Larsen LB, Hansen LB. Drugs in injured drivers in Denmark. Forensic Sci Int 2005;150: 181-189
71. Kintz P, Bernhard W, Villain M, Gasser M, Aebi B, Cirimele V. Detection of cannabis use in drivers with the Drugwipe device and by GC-MS after Intercept device collection. J Anal Toxicol 2005;29:724-727 (Pubitemid 41803365)
72. Ojaniemi KK, Lintonen TP, Impinen AO, Lillsunde PM, Ostamo AI. Trends in driving under the influence of drugs: a register-based study of DUID suspects during 1977-2007. Accid Anal Prev 2009;41:191-196
73. Cook JM, Marshall R, Masci C, Coyne JC. Physicians' perspectives on prescribing benzodiazepines for older adults: a qualitative study. J Gen Intern Med 2007;22:303-307 (Pubitemid 46941221)
74. Cone EJ, Clarke J, Tsanaclis L. Prevalence and disposition of drugs of abuse and opioid treatment drugs in oral fluid. J Anal Toxicol 2007; 31:424-433 (Pubitemid 350164283)
75. Pil K, Raes E, Van den Neste T, Verstraete A. Toxicological analyses in the DRUID epidemiological studies: analytical methods, target analytes and analytical cut-offs. From: The International Association of Forensic Toxicology annual meeting; 2007 Aug 27-30; Seattle.
76. Clarke J, Wilson JF. Proficiency testing (external quality assessment) of drug detection in oral fluid. Forensic Sci Int 2005;150:161-164 (Pubitemid 41583218)
77. Ananias D, Mountain L, Zhao Y, Blum K, Fritch D, Kardos K, Lee S. Automated immunoassays for the detection of opiates, amphetamines and methamphetamines in oral fluid on Roche instrument panels. Ther Drug Monit 2007;29:493.
78. Barnes AJ, Kim I, Schepers R, Moolchan ET, Wilson L, Cooper G, et al. Sensitivity, specificity, and efficiency in detecting opiates in oral fluid with the Cozart opiate microplate EIA and GC-MS following controlled codeine administration. J Anal Toxicol 2003;27:402-406 (Pubitemid 37185848)
79. Cooper G, Wilson L, Reid C, Baldwin D, Hand C, Spiehler V. Comparison of GC-MS and EIA results for the analysis of methadone in oral fluid. J Forensic Sci 2005;50:928-932 (Pubitemid 40917813)
80. Apollonio LG, Whittall IR, Pianca DJ, Kyd JM, Maher WA. Matrix effect and cross-reactivity of select amphetamine-type substances, designer analogues, and putrefactive amines using the Bio-Quant Direct ELISA presumptive assays for amphetamine and methamphetamine. J Anal Toxicol 2007;31:208-213
81. Kim I, Barnes AJ, Schepers R, Moolchan ET, Wilson L, Cooper G, et al. Sensitivity and specificity of the Cozart microplate EIA cocaine oral fluid at proposed screening and confirmation cutoffs. Clin Chem 2003;49:1498-1503 (Pubitemid 37011738)
82. Kolbrich EA, Kim I, Barnes AJ, Moolchan ET, Wilson L, Cooper GA, et al. Cozart RapiScan oral fluid drug testing system: an evaluation of sensitivity, specificity, and efficiency for cocaine detection compared with ELISA and GC-MS following controlled cocaine administration. J Anal Toxicol 2003;27:407-411 (Pubitemid 37185849)
83. Smink BE, Mathijssen MPM, Lusthof KJ, de Gier JJ, Egberts ACG, Uges DRA. Comparison of urine and oral fluid as matrices for screening of thirty-three benzodiazepines and benzodiazepine-like substances using immunoassay and LC-MS(-MS). J Anal Toxicol 2006;30:478-485
84. Crouch DJ, Walsh JM, Flegel R, Cangianelli L, Baudys J, Atkins R. An evaluation of selected oral fluid point-of-collection drug-testing devices. J Anal Toxicol 2005;29:244-248 (Pubitemid 40827571)
85. Wilson L, Jehanli A, Hand C, Cooper G, Smith R. Evaluation of a rapid oral fluid point-of-care test for MDMA. J Anal Toxicol 2007;31:98-104. (Pubitemid 46557481)
86. Laloup M, Del Mar Ramirez Fernandez M, Wood M, De Boeck G, Maes V, Samyn N. Correlation of Delta9-tetrahydrocannabinol concentrations determined by LC-MS-MS in oral fluid and plasma from impaired drivers and evaluation of the on-site Drager DrugTest. Forensic Sci Int 2006;161:175-179 (Pubitemid 44142907)
87. Cirimele V, Villain M, Mura P, Bernard M, Kintz P. Oral fluid testing for cannabis: on-site Ora- Line IV s.a.t. device versus GC/MS. Forensic Sci Int 2006;161:180-184 (Pubitemid 44142908)
88. Kempf J, Wuske T, Schubert R, Weinmann W. Pre-analytical stability of selected benzodiazepines on a polymeric oral fluid sampling device. Forensic Sci Int 2009;186:81-85
89. Dams R, Choo RE, Lambert WE, Jones H, Huestis MA. Oral fluid as an alternative matrix to monitor opiate and cocaine use in substance-abuse treatment patients. Drug Alcohol Depend 2007; 87:258-267 (Pubitemid 46215928)
90. Gunnar T, Ariniemi K, Lillsunde P. Validated toxicological determination of 30 drugs of abuse as optimized derivatives in oral fluid by long column fast gas chromatography/electron impact mass spectrometry. J Mass Spectrom 2005; 40:739-753 (Pubitemid 40905239)
91. Wylie FM, Torrance H, Anderson RA, Oliver JS. Drugs in oral fluid, part I: validation of an analytical procedure for licit and illicit drugs in oral fluid. Forensic Sci Int 2005;150:191-198 (Pubitemid 41583222)
92. Øiestad EL, Johansen U, Christophersen AS. Drug screening of preserved oral fluid by liquid chromatography-tandem mass spectrometry. Clin Chem 2007;53:300-309
93. Pujadas M, Pichini S, Civit E, Santamariña E, Perez K, de la Torre R. A simple and reliable procedure for the determination of psychoactive drugs in oral fluid by gas chromatography-mass spectrometry. J Pharm Biomed Anal 2007;44: 594-601. (Pubitemid 46880095)
94. Concheiro M, de Castro A, Quintela O, Cruz A, López-Rivadulla M. Determination of illicit and medicinal drugs and their metabolites in oral fluid and preserved oral fluid by liquid chromatography-tandem mass spectrometry. Anal Bioanal Chem 2008;391:2329-2338
95. Fernandez P, Morales L, Vazquez C, Lago M, Bermejo AM. Comparison of two extraction procedures for determination of drugs of abuse in human saliva by high-performance liquid chromatography. J Appl Toxicol 2008;28:998-1003.
96. Kala SV, Harris SE, Freijo TD, Gerlich S. Validation of analysis of amphetamines, opiates, phencyclidine, cocaine, and benzoylecgonine in oral fluids by liquid chromatographytandem mass spectrometry. J Anal Toxicol 2008;32:605-611
97. Sergi M, Bafile E, Compagnone D, Curini R, D'Ascenzo G, Romolo FS. Multiclass analysis of illicit drugs in plasma and oral fluids by LC-MS/MS. Anal Bioanal Chem 2009;393:709-718 (Pubitemid 50319637)
98. Concheiro M, de Castro A, Quintela O, Cruz A, Lopez-Rivadulla M. Development and validation of a method for the quantitation of Delta9-tetrahydrocannabinol in oral fluid by liquid chromatography electrospray-mass-spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci 2004;810:319-324 (Pubitemid 39243321)
99. Teixeira H, Proenca P, Castanheira A, Santos S, Lopez-Rivadulla M, Corte-Real F, et al. Cannabis and driving: the use of LC-MS to detect delta9-tetrahydrocannabinol (delta9-THC) in oral fluid samples. Forensic Sci Int 2004;146(Suppl): S61-3.
100. Laloup M, Ramirez Fernandez Mdel M, Wood M, De Boeck G, Henquet C, Maes V, Samyn N. Quantitative analysis of delta9-tetrahydrocannabinol in preserved oral fluid by liquid chromatography-tandem mass spectrometry. J Chromatogr 2005; 1082:15-24. (Pubitemid 40848584)
101. Teixeira H, Proenca P, Verstraete A, Corte-Real F, Vieira DN. Analysis of Delta-9-tetrahydrocannabinol in oral fluid samples using solid-phase extraction and high-performance liquid chromatography-electrospray ionization mass spectrometry. Forensic Sci Int 2005;150: 205-211 (Pubitemid 41583224)
102. Day D, Kuntz DJ, Feldman M, Presley L. Detection of THCA in oral fluid by GC-MS-MS. J Anal Toxicol 2006;30:645-650 (Pubitemid 44913015)
103. Moore C, Rana S, Coulter C. Simultaneous identification of 2-carboxy-tetrahydrocannabinol, tetrahydrocannabinol, cannabinol and cannabidiol in oral fluid. J Chromatogr B Analyt Technol Biomed Life Sci 2007;852:459-464 (Pubitemid 46830152)
104. Quintela O, Andrenyak DM, Hoggan AM, Crouch DJ. A validated method for the detection of Delta(9)-tetrahydrocannabinol and 11-nor-9-carboxy-Delta(9)- tetrahydrocannabinol in oral fluid samples by liquid chromatography coupled with quadrupole-time-of-flight mass spectrometry. J Anal Toxicol 2007;31:157-164
105. Teixeira H, Verstraete A, Proenca P, Corte-Real F, Monsanto P, Vieira DN. Validated method for the simultaneous determination of Delta9-THC and Delta9-THC-COOH in oral fluid, urine and whole blood using solid-phase extraction and liquid chromatography-mass spectrometry with electrospray ionization. Forensic Sci Int 2007; 170:148-155 (Pubitemid 47088879)
106. Campora P, Bermejo AM, Tabernero MJ, Fernandez P. Use of gas chromatography/mass spectrometry with positive chemical ionization for the determination of opiates in human oral fluid. Rapid Commun Mass Spectrom 2006;20: 1288-1292
107. Phillips SG, Allen KR. Acetylcodeine as a marker of illicit heroin abuse in oral fluid samples. J Anal Toxicol 2006;30:370-374
108. Rana S, Moore C, Vincent M, Coulter C, Agrawal A, Soares J. Determination of propoxyphene in oral fluid. J Anal Toxicol 2006;30:516-518
109. Martins LF, Yegles M, Wennig R. Simultaneous enantio selective quantification of methadone and of 2-ethylidene-1,5-dimethyl-3,3- diphenylpyrrolidine in oral fluid using capillary electrophoresis. J Chromatogr B Analyt Technol Biomed Life Sci 2008;862:79-85.
110. Kankaanpää A, Gunnar T, Ariniemi K, Lillsunde P, Mykkänen S, Seppälä T. Single-step procedure for gas chromatography-mass spectrometry screening and quantitative determination of amphetamine-type stimulants and related drugs in blood, serum, oral fluid and urine samples. J Chromatogr B Analyt Technol Biomed Life Sci 2004;810:57-68. (Pubitemid 39195024)
111. Concheiro M, de Castro A, Quintela O, Lopez-Rivadulla M, Cruz A. Determination of MDMA, MDA, MDEA and MBDB in oral fluid using high performance liquid chromatography with native fluorescence detection. Forensic Sci Int 2005; 150:221-226 (Pubitemid 41583226)
112. Scheidweiler KB, Huestis MA. Monitoring of ecstasy (MDMA) and three metabolites in oral fluid. From: The National Institute on Drug Abuse Frontiers in Addiction Research satellite event at the Society for Neuroscience annual meeting; 2005 Nov 11; Washington, DC.
113. Scheidweiler KB, Huestis MA. A validated gas chromatographic-electron impact ionization mass spectrometric method for methylenedioxymethamphetamine (MDMA), methamphetamine and metabolites in oral fluid. J Chromatogr B Analyt Technol Biomed Life Sci 2006; 835:90-99
114. Moore C, Coulter C, Crompton K. Achieving proposal federal concentration using reduced specimen volume for the extraction of amphetamines from oral fluid. J Anal Toxicol 2007;31: 442-446 (Pubitemid 350164285)
115. Clauwaert K, Decaestecker T, Mortier K, Lambert W, Deforce D, Van Peteghem C, Van Bocxlaer J. The determination of cocaine, benzoylecgonine, and cocaethylene in small-volume oral fluid samples by liquid chromatography- quadrupole-time-of-flight mass spectrometry. J Anal Toxicol 2004;28:655-659 (Pubitemid 39489039)
116. Robarge T, Phillips E, Edwards J, Seiter W, Presley L, Hollaway D. Positive ion chemical ionization and gas chromatography/quadrupole mass spectrometry for confirmation and quantitation of benzoylecgonine in oral fluid. LCGC Europe 2005 Dec 2.
117. Cognard E, Bouchonnet S, Staub C. Validation of a gas chromatography-ion trap tandem mass spectrometry for simultaneous analyse of cocaine and its metabolites in saliva. J Pharm Biomed Anal 2006;41:925-934
118. Quintela O, Cruz A, Concheiro M, de Castro A, Lopez-Rivadulla M. A sensitive, rapid and specific determination of midazolam in human plasma and saliva by liquid chromatography/electrospray mass spectrometry. Rapid Commun Mass Spectrom 2004;18:2976-2982 (Pubitemid 39664896)
119. Kintz P, Villain M, Concheiro M, Cirimele V. Screening and confirmatory method for benzodiazepines and hypnotics in oral fluid by LC-MS/MS. Forensic Sci Int 2005;150:213-220 (Pubitemid 41583225)
120. Quintela O, Cruz A, Castro A, Concheiro M, Lopez-Rivadulla M. Liquid chromatography-electrospray ionization mass spectrometry for the determination of nine selected benzodiazepines in human plasma and oral fluid. J Chromatogr B Analyt Technol Biomed Life Sci 2005;825:63-71. (Pubitemid 41262479)
121. Link B, Haschke M, Wenk M, Krahenbuhl S. Determination of midazolam and its hydroxy metabolites in human plasma and oral fluid by liquid chromatography/electrospray ionization ion trap tandem mass spectrometry. Rapid Commun Mass Spectrom 2007;21:1531-1540 (Pubitemid 46761975)
122. Moore C, Coulter C, Crompton K, Zumwalt M. Determination of benzodiazepines in oral fluid using LC-MS-MS. J Anal Toxicol 2007;31:596-600. (Pubitemid 350291673)
123. Ngwa G, Fritch D, Blum K, Newland G. Simultaneous analysis of 14 benzodiazepines in oral fluid by solid-phase extraction and LC-MS-MS. J Anal Toxicol 2007;31:369-376 (Pubitemid 47451064)
124. Uddin MN, Samanidou VF, Papadoyannis IN. Validation of SPE-HPLC determination of 1,4-benzodiazepines and metabolites in blood plasma, urine, and saliva. J Sep Sci 2008;31: 3704-3717
125. Jehanli A, Brannan S, Moore L, Spiehler VR. Blind trials of an onsite saliva drug test for marijuana and opiates. J Forensic Sci 2001;46:1214-1220 (Pubitemid 33089435)
126. Sharp ME, Wallace SM, Hindmarsh KW, Peel HW. Monitoring saliva concentrations of methaqualone, codeine, secobarbital, diphenhydramine and diazepam after single oral doses. J Anal Toxicol 1983;7:11-14
127. Cone EJ. Testing human hair for drugs of abuse, I: individual dose and time profiles of morphine and codeine in plasma, saliva, urine, and beard compared to drug-induced effects on pupils and behavior. J Anal Toxicol 1990;14:1-7.
128. Chen ZR, Somogyi AA, Reynolds G, Bochner F. Disposition and metabolism of codeine after single and chronic doses in one poor and seven extensive metabolisers. Br J Clin Pharmacol 1991;31:381-390
129. O'Neal CL, Crouch DJ, Rollins DE, Fatah A, Cheever ML. Correlation of saliva codeine concentrations with plasma concentrations after oral codeine administration. J Anal Toxicol 1999;23:452-459 (Pubitemid 29473397)
130. O'Neal CL, Crouch DL, Rollins DE, Fatah AA. The effects of collection methods on oral fluid codeine concentrations. J Anal Toxicol 2000;24:536-542